Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Effects of continuous positive airway pressure on neurocognitive and neuropsychiatric function in obstructive sleep apnea

V. Dostálová, S. Kolečkárová, M. Kuška, M. Pretl, O. Bezdicek,

. 2019 ; 28 (5) : e12761. [pub] 20180920

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc20023641

The aim of this study was to determine the neurocognitive and neuropsychiatric effects of continuous positive airway pressure treatment on patients with obstructive sleep apnea. This cross-sectional, prospective, observational study included 126 patients with sleep apnea. The following tests were performed: the Montreal Cognitive Assessment for the evaluation of cognitive impairment, the Beck Depression Inventory, and the State-Trait Anxiety Inventory, together with the Epworth Sleepiness Scale for the evaluation of neuropsychiatric symptoms and a person's general level of daytime sleepiness. The first measurement did not show neurocognitive impairment or a higher level of depressive and anxiety symptoms in 126 patients with obstructive sleep apnea in comparison to normative standards. After the 3-month treatment indicated for 43 patients with obstructive sleep apnea, we did not find any significant improvement in cognitive performance (p = .213). However, patients with sleep apnea with continuous positive airway pressure treatment did show significantly less daytime sleepiness, anxiety and depressive symptoms (all p < .001). In conclusion, short-term (3 months) treatment of patients with obstructive sleep apnea can substantially alleviate their daytime sleepiness, as well as depressive and anxiety symptoms.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023641
003      
CZ-PrNML
005      
20240723092218.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jsr.12761 $2 doi
035    __
$a (PubMed)30238529
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Dostálová, Veronika $u Prague College of Psychosocial Studies, Prague, Czech Republic. INSPAMED, Neurology and Sleep Laboratory, Institute of Sleep Medicine, Prague, Czech Republic. Diamant Neuropsychology Laboratory, Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, General University Hospital, Charles University, Prague, Czech Republic. $7 xx0320210
245    10
$a Effects of continuous positive airway pressure on neurocognitive and neuropsychiatric function in obstructive sleep apnea / $c V. Dostálová, S. Kolečkárová, M. Kuška, M. Pretl, O. Bezdicek,
520    9_
$a The aim of this study was to determine the neurocognitive and neuropsychiatric effects of continuous positive airway pressure treatment on patients with obstructive sleep apnea. This cross-sectional, prospective, observational study included 126 patients with sleep apnea. The following tests were performed: the Montreal Cognitive Assessment for the evaluation of cognitive impairment, the Beck Depression Inventory, and the State-Trait Anxiety Inventory, together with the Epworth Sleepiness Scale for the evaluation of neuropsychiatric symptoms and a person's general level of daytime sleepiness. The first measurement did not show neurocognitive impairment or a higher level of depressive and anxiety symptoms in 126 patients with obstructive sleep apnea in comparison to normative standards. After the 3-month treatment indicated for 43 patients with obstructive sleep apnea, we did not find any significant improvement in cognitive performance (p = .213). However, patients with sleep apnea with continuous positive airway pressure treatment did show significantly less daytime sleepiness, anxiety and depressive symptoms (all p < .001). In conclusion, short-term (3 months) treatment of patients with obstructive sleep apnea can substantially alleviate their daytime sleepiness, as well as depressive and anxiety symptoms.
650    _2
$a trvalý přetlak v dýchacích cestách $x metody $7 D045422
650    _2
$a průřezové studie $7 D003430
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neurokognitivní poruchy $x etiologie $x patologie $7 D019965
650    _2
$a neuropsychologické testy $x normy $7 D009483
650    _2
$a prospektivní studie $7 D011446
650    _2
$a obstrukční spánková apnoe $x patofyziologie $7 D020181
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kolečkárová, Sandra $u Prague College of Psychosocial Studies, Prague, Czech Republic. Psychiatric Hospital in Dobřany, Dobřany, Czech Republic.
700    1_
$a Kuška, Martin $u Prague College of Psychosocial Studies, Prague, Czech Republic. Olomouc University Social Health Institute, Palacký University, Olomouc, Czech Republic.
700    1_
$a Pretl, Martin $u INSPAMED, Neurology and Sleep Laboratory, Institute of Sleep Medicine, Prague, Czech Republic.
700    1_
$a Bezdicek, Ondrej $u Prague College of Psychosocial Studies, Prague, Czech Republic. Diamant Neuropsychology Laboratory, Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, General University Hospital, Charles University, Prague, Czech Republic.
773    0_
$w MED00002940 $t Journal of sleep research $x 1365-2869 $g Roč. 28, č. 5 (2019), s. e12761
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30238529 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20240723092215 $b ABA008
999    __
$a ok $b bmc $g 1595960 $s 1114317
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 28 $c 5 $d e12761 $e 20180920 $i 1365-2869 $m Journal of sleep research $n J Sleep Res $x MED00002940
LZP    __
$a Pubmed-20201125
Back

Find record

Citation metrics

Archiving options